An observational study in Retinoblastoma and Pineoblastoma, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to participants aged 1 Day to 50 Years. Per ClinicalTrials.gov, last updated 2015-12-29.
Sponsored by Charite University, Berlin, Germany · Observational
MRI is useful for diagnosing pinealoblastoma in retinoblastoma patients
124 studies on the registry are indexed under Retinoblastoma; 23 are open to participants now.
This study's enrollment of 80 is below the median of 224 across 34 observational studies indexed under Retinoblastoma.
Browse Retinoblastoma studies →Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 129 are open to participants now.
Counted across the registry records on this site, refreshed daily.
pediatric patients with retinoblastoma
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
patients with diagnosed retinoblastoma
aged matched control cohort without the diagnosis of ocular or brain tumor
Malignancy criteria of pineal gland
size of pineal gland solid or cystic component (all at baseline)
Time frame: clinical follow-up 1-year after baseline imaging
This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →